Rossari Biotech Limited will participate in the Anand Rathi Annual Flagship Conference G-200 Summit 2026 on Tuesday, September 22, 2026. The event will feature one-on-one and group discussions with investors and analysts.

The company disclosed the schedule pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting is scheduled to begin at 2:00 pm IST in Mumbai.

Meeting Details

The discussions will focus on financial and other information already available to the public. This includes data covered in the earnings presentation submitted to stock exchanges on July 19, 2026.

Key Notes

• The date and time are subject to change due to exigencies.
• No unpublished price-sensitive information will be shared during the meeting.

Parul Gupta, Company Secretary & Head - Legal, signed the intimation letter dated September 16, 2026.

Rossari Biotech Limited has withdrawn its participation from the Nirmal Bang Semi-Annual Investor Conference scheduled for August 10, 2026, reversing a prior disclosure of its intent to attend. The company notified the stock exchanges of this change on August 06, 2026, citing an inability to participate in the planned one-on-one and group sessions in Mumbai. This development means investors will not have the opportunity to engage with management during the event as originally anticipated.

The intimation was submitted pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Rossari Biotech referenced its earlier letter dated August 03, 2026, which had confirmed the company’s scheduled appearance at the conference. The updated disclosure explicitly states that the company "could not participate" in the event, superseding the previous announcement.

Withdrawal Details

Parul Gupta, Company Secretary & Head - Legal at Rossari Biotech, signed the non-participation notice on August 06, 2026. The communication was dispatched to both BSE Limited and the National Stock Exchange of India Limited for dissemination to stakeholders. No specific reason for the withdrawal, such as operational exigencies or management unavailability, was provided in the filing beyond the general statement of inability to participate.

Compliance Note

The company requested that the exchanges take the non-participation on record and disseminate the information to all concerned parties. This update ensures that market participants are aware that the previously announced interaction with Rossari Biotech management will not take place, allowing investors to adjust their schedules accordingly.